Hormone Therapy News

In this video exclusive, Susan Samson, MD, PhD, FRCPC, FACE, associate professor in the department of endocrinology, diabetes and metabolism at Baylor College of Medicine in Houston and program chair for the American Association of Clinical Endocrinologists annual meeting describes highlights of this year’s sessions.

Endocrine Today has compiled a list of recent FDA news stories relating to endocrine practice. Drugs under consideration included those for osteoporosis, diabetes, overweight and obesity, hypoactive sexual desire disorder and hypogonadism.

Among postmenopausal women with hormone receptor positive breast cancer prescribed adjuvant endocrine therapies, those with an intimate partner are more likely to report a higher psychosocial quality of life despite sexual symptoms related to treatment when compared with similar, unpartnered women, according to findings from a cross-sectional study published in Menopause.

Researchers from Georgia Tech developed and performed initial testing for contraceptive patches administered via jewelry that could provide a new avenue for birth control, according to findings presented in the Journal of Controlled Release.

The FDA on Thursday approved marketing of a generic version of testosterone gel 1.62% as replacement therapy for men with hypogonadism, according to a press release from Lupin.

An analysis of transgender teens prescribed spironolactone showed that only 2.2% developed hyperkalemia after initiating therapy, with all cases resolving upon repeat measurement irrespective of spironolactone dose, according to findings published in the Journal of the Endocrine Society.

Endocrine Today has compiled a list of the top five news stories posted from the Endocrine Society Annual Meeting, held March 23–26 in New Orleans.

Endocrine Today has compiled a list of the top recent news reports related to testosterone therapy. In March, Healio.com/Endocrinology readers were interested in essential oils disrupting endocrine function, semaglutide producing weight loss and the safety of an artificial pancreas.

Transgender patients had an increased risk for MI compared with cisgender patients, according to data presented at the American Heart Association Quality of Care and Outcomes Research Scientific Sessions.

Children with idiopathic short stature and normal but early pubertal timing may see an increase in adult height when prescribed combination growth hormone and gonadotropin-releasing hormone analogue therapy, according to findings published in The Journal of Clinical Endocrinology & Metabolism.